New immune cell therapy tested for leukemia that Won't quit
NCT ID NCT05358808
Summary
This study tested an experimental cell therapy called TCB008 for adults with acute myeloid leukemia (AML) or related conditions where the cancer has returned or not responded to standard treatments. The therapy involves infusing specially grown immune cells from healthy donors to help the patient's body fight the cancer. The main goals were to see if the treatment could reduce cancer cells and how well patients responded, while closely monitoring safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bristol and Weston NHS foundation trust
Bristol, BS2 8ED, United Kingdom
-
Cardiff and Vale University LHB
Cardiff, CF14 4HH, United Kingdom
-
Guys&St Thomas NHS foundation Trust
London, SE1 7EH, United Kingdom
-
Kings College Hospital
London, SE5 9RS, United Kingdom
-
Queen Elizabeth University Hospital
Glasgow, G51 4TF, United Kingdom
-
Royal Marsden Hospital
London, SW3 6JJ, United Kingdom
Conditions
Explore the condition pages connected to this study.